Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

PTH mimic peptide and application thereof

A technology that mimics peptides and amino acids, applied in the biological field, can solve problems such as unachieved effects, and achieve the effects of promoting fracture healing, promoting osteoblast differentiation, and improving clinical medicinal value.

Active Publication Date: 2017-02-01
杨德鸿
View PDF1 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The effect of PTH (1-34) is far from the effect of clinical needs

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • PTH mimic peptide and application thereof
  • PTH mimic peptide and application thereof
  • PTH mimic peptide and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] The PTH receptor (PTHR1) gene was transfected into HEK293 cell line (not expressing PTHR1), and cell clones stably expressing PTHR1 were selected (the PTHR1 receptor gene has been inserted into the genome of HEK293 cells, and the expression of the receptor gene is stable; hereinafter referred to as HEK293- PTHR1 cells). For experimental results, see figure 1 .

[0034] From figure 1 A can see that (10 -5 M) PTH (3-34), MY-1 peptide (10 -5 M, 10 -6 M) Stimulation for 4 hours could not activate the PLC signal in HEK293-PTHR1 cells to increase the production of IP, but PTH(1-34) had the function of activating PLC. figure 1 B shows PTH(3-34)(10 -5 M), MY-1 peptide (10 -5 M, 10 -6 M) 4-hour stimulation fails to promote cAMP production in HEK293-PTHR1 cells.

[0035] In order to detect the activation of PKC in cells, we transfected HEK193-PTHR1 cells (HEK193-PTHR1-CKAR cells) with PKC activation fluorescent detection molecule CKAR (Note: If PKC is activated, it will ...

Embodiment 2

[0040] Example 2: Inhibition of osteoblast apoptosis by MY-1 peptide and MMY-1

[0041] The osteoblast cell line MC3T3-E1 was treated with 4x10 5 Inoculate such as 24-well plate at the density of each well, and when the cell density in the well reaches 80% (leading to microscope observation and measurement), replace the 10% serum + α-MEM medium with 1% serum + α-MEM medium to continue culturing 24 hours, 10 -6 MY-1 peptide of M, 10 -6 MMY-1 peptide of M and 10 -8 M PTH (1-34) was added with 1% serum + α-MEM medium to continue culturing for 4 hours, then digested with 0.05% trypsin to prepare suspension cells, PI (stained damaged nuclei) and FITC (stained damaged nuclei) Cell membrane) staining solution was incubated at 4°C for 20 minutes, and the flow cytometer classified and counted the percentages of cells according to the staining conditions of PI and FITC, among which PI + FITC + The cell population is late apoptotic or dead cells, PI - FITC + early apoptotic cells....

Embodiment 3

[0045] Example 3: MY-1 peptide and MMY-1 promote osteoblast expression of osteogenic gene alkaline phosphatase

[0046] Inoculate the osteoblast cell line MC3T3-E1 with a density of 1x106 / hole, such as a 6-well plate, and when the cell density in the well reaches 80% (leading to microscope observation and measurement), replace the 10% serum + α-MEM medium with 1% Serum+α-MEM medium continued to culture for 24 hours, 10 -6 MY-1 peptide of M, 10 -6 MMY-1 peptide of M and 10 -8 MPTH (1-34) was added to α-MEM medium to continue culturing for 4 hours, then total RNA was extracted, and the expression of alkaline phosphatase (ALP) was detected by quantitative PCR.

[0047] Such as figure 2 As shown, PTH(1-34), MY-1 peptide and MMY-1 peptide can significantly promote the expression of osteoblast osteogenesis gene ALP.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a novel PTH mimic peptide. The PTH mimic peptide can specifically activate PLC data-independent and PKA data-independent PKC signal pathways, and can further promote bone cell differentiation and fracture healing; part of the effect is better than that of PTH (1-34). The PTH mimic peptide has extremely good scientific research application and clinical medicinal value for treating osteoporosis.

Description

technical field [0001] The invention belongs to the field of biotechnology, and in particular relates to a PTH mimic peptide and its application. Background technique [0002] Osteoporosis can be defined as a systemic skeletal disorder characterized by low bone mass, microstructural deterioration of bone tissue, and increased bone fragility and susceptibility to fracture. Osteoporosis is a common disease that seriously affects the health and life of the elderly. At present, common drugs for the treatment of osteoporosis include anti-resorptive drugs and osteosynthetic drugs. The former cannot effectively improve bone quality and requires long-term medication. The latter can quickly improve bone quality and prevent fractures, especially for severe osteoporosis. The loosening effect is obvious. [0003] Parathyroid hormone (PTH) is a polypeptide hormone secreted by the parathyroid gland and is an important factor in regulating calcium and phosphorus metabolic balance in orga...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K14/635A61K38/29A61P19/10
CPCA61K38/00C07K14/635
Inventor 杨德鸿闫文娟
Owner 杨德鸿
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com